SCHEMBL17933342

SCHEMBL17933342

CC(=O)[C@@H](N)Cc1cnc(P(=O)(O)O)cn1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17936286 0.86 CYP1A2 (0.42) PTPRC
SCHEMBL17933360 0.83 ALDH1A1 (0.32) —
SCHEMBL16561826 0.82 FDPS (0.31) —
SCHEMBL17933371 0.78 GRM8 (0.30) —
SCHEMBL17933341 0.78 — —
SCHEMBL17933350 0.78 GRM8 (0.30) —
SCHEMBL17933334 0.78 FDPS (0.36) PTPRC
SCHEMBL17933348 0.73 GRM8 (0.33) PTPRC
SCHEMBL17933339 0.72 PTPRC (0.31) PTPRC
SCHEMBL14338236 0.71 ADORA3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160207948-A1 PHOSPHOHISTIDINE AND PHOSPHOTYROSINE ANALOGUES UNIVERSITY OF SHEFFIELD (GB) 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207948-A1 PHOSPHOHISTIDINE AND PHOSPHOTYROSINE ANALOGUES HRH3, CYTH3, CYTH2 PTPRC 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback